BioMarin (Phase III PARP) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

BioMarin (Phase III PARP) General Information

Description

Drugs for the treatment of breast cancer. The treatment specializes in orally-available poly ADP ribose polymerase (PARP)

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Corporate Office
  • 770 Lindaro Street
  • San Rafael, CA 94901
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioMarin (Phase III PARP) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BioMarin (Phase III PARP)‘s full profile, request access.

Request a free trial

BioMarin (Phase III PARP) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore BioMarin (Phase III PARP)‘s full profile, request access.

Request a free trial

BioMarin (Phase III PARP) FAQs

  • Where is BioMarin (Phase III PARP) headquartered?

    BioMarin (Phase III PARP) is headquartered in San Rafael, CA.

  • What industry is BioMarin (Phase III PARP) in?

    BioMarin (Phase III PARP)’s primary industry is Buildings and Property.

  • Is BioMarin (Phase III PARP) a private or public company?

    BioMarin (Phase III PARP) is a Private company.

  • What is the current valuation of BioMarin (Phase III PARP)?

    The current valuation of BioMarin (Phase III PARP) is 00000.

  • What is BioMarin (Phase III PARP)’s current revenue?

    The current revenue for BioMarin (Phase III PARP) is 000000.

  • Who are BioMarin (Phase III PARP)’s investors?

    BioMarin Pharmaceutical has invested in BioMarin (Phase III PARP).

  • When was BioMarin (Phase III PARP) acquired?

    BioMarin (Phase III PARP) was acquired on 24-Aug-2015.

  • Who acquired BioMarin (Phase III PARP)?

    BioMarin (Phase III PARP) was acquired by Medivation.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »